Variant report

Variant	rs61626064
Chromosome Location	chr15:50401637-50401638
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 37 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:32)

rs_ID	r²[population]
rs10162988	1.00[AMR][1000 genomes]
rs28378462	1.00[AMR][1000 genomes]
rs28430678	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs28435529	1.00[AMR][1000 genomes]
rs28452447	1.00[AMR][1000 genomes]
rs28483908	1.00[AMR][1000 genomes]
rs28488704	1.00[AMR][1000 genomes]
rs28503500	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs28547013	1.00[AMR][1000 genomes]
rs28624511	1.00[AMR][1000 genomes]
rs28665904	1.00[AMR][1000 genomes]
rs28694140	1.00[AMR][1000 genomes]
rs28694493	1.00[AMR][1000 genomes]
rs28695746	1.00[AMR][1000 genomes]
rs28720873	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56654392	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs57191911	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs57210505	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs59021616	1.00[AMR][1000 genomes]
rs60436593	1.00[AMR][1000 genomes]
rs60959211	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs7163385	1.00[AMR][1000 genomes]
rs73400825	1.00[AMR][1000 genomes]
rs73400834	1.00[AMR][1000 genomes]
rs73400842	1.00[AMR][1000 genomes]
rs73400860	0.84[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73400867	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73400871	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73400878	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73400879	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73400880	0.80[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9920507	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1044277	chr15:49921547-50702386	Enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	107 gene(s)	inside rSNPs	diseases
2	nsv542380	chr15:49921547-50702386	Enhancers Strong transcription Weak transcription Genic enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	107 gene(s)	inside rSNPs	diseases
3	nsv1035983	chr15:50223334-50595170	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
4	nsv542382	chr15:50223334-50595170	Weak transcription Enhancers Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
5	nsv569395	chr15:50345393-50437494	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:45 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:50398800-50403200	Enhancers	Primary T cells from cord blood	blood
2	chr15:50399200-50403000	Enhancers	Primary T helper cells PMA-I stimulated	--
3	chr15:50399200-50407200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
4	chr15:50399400-50402000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
5	chr15:50399400-50402000	Enhancers	Fetal Thymus	thymus
6	chr15:50399400-50402200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr15:50399400-50402200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr15:50399400-50403800	Enhancers	Thymus	Thymus
9	chr15:50399800-50401800	Enhancers	Primary T cells fromperipheralblood	blood
10	chr15:50399800-50407800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
11	chr15:50400000-50402000	Enhancers	Primary T helper cells fromperipheralblood	blood
12	chr15:50400000-50402400	Enhancers	Primary T helper naive cells from peripheral blood	blood
13	chr15:50400200-50402000	Enhancers	Dnd41	blood
14	chr15:50400400-50401800	Enhancers	Primary B cells from cord blood	blood
15	chr15:50400400-50402600	Enhancers	Breast Myoepithelial Primary Cells	Breast
16	chr15:50400600-50401800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
17	chr15:50400600-50401800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
18	chr15:50400600-50401800	Active TSS	Brain Hippocampus Middle	brain
19	chr15:50400600-50401800	Enhancers	Right Atrium	heart
20	chr15:50400600-50402000	Flanking Active TSS	Primary hematopoietic stem cells	blood
21	chr15:50400600-50402000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
22	chr15:50400600-50402000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr15:50400800-50401800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
24	chr15:50400800-50401800	Enhancers	Adipose Nuclei	Adipose
25	chr15:50400800-50402200	Enhancers	Primary T killer memory cells from peripheral blood	blood
26	chr15:50400800-50402800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
27	chr15:50400800-50403600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr15:50401000-50404600	Weak transcription	Duodenum Mucosa	Duodenum
29	chr15:50401200-50401800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr15:50401200-50402000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr15:50401200-50402000	Enhancers	Rectal Mucosa Donor 29	rectum
32	chr15:50401200-50402000	Enhancers	HMEC	breast
33	chr15:50401200-50402000	Enhancers	NHEK	skin
34	chr15:50401200-50402000	Enhancers	Osteobl	bone
35	chr15:50401200-50402200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr15:50401200-50402200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr15:50401200-50402200	Enhancers	Liver	Liver
38	chr15:50401400-50402600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
39	chr15:50401400-50403800	Weak transcription	K562	blood
40	chr15:50401400-50404800	Weak transcription	Duodenum Smooth Muscle	Duodenum
41	chr15:50401400-50405000	Weak transcription	Spleen	Spleen
42	chr15:50401600-50402000	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
43	chr15:50401600-50402000	Enhancers	Muscle Satellite Cultured Cells	--
44	chr15:50401600-50402000	Enhancers	NHDF-Ad	bronchial
45	chr15:50401600-50402200	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links